Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5290]

SABCS 2024: Longer-term NATALEE data shows durable reduction in distant recurrence in broad population of patients with early breast cancer

SABCS 2024: Longer-term NATALEE data shows durable reduction in distant recurrence in broad population of patients...

Reiki therapy demonstrates significant symptom relief for cancer patients receiving infusion treatments

Reiki therapy demonstrates significant symptom relief for cancer patients receiving infusion treatments

Tracking immune cell brain cancer therapies with ultrasound

Tracking immune cell brain cancer therapies with ultrasound

Breakthroughs in cell-penetrating monoclonal antibody therapies

Breakthroughs in cell-penetrating monoclonal antibody therapies

HBx facilitates drug resistance in hepatocellular carcinoma via CD133-regulated self-renewal of liver cancer stem cells

HBx facilitates drug resistance in hepatocellular carcinoma via CD133-regulated self-renewal of liver cancer stem...

ASH 2024: Longer-term data for asciminib reinforce superior efficacy with favourable safety and tolerability...

ASH 2024: Study finds genetic changes, elevated leukaemia risk in ground zero first responders

ASH 2024: Study finds genetic changes, elevated leukaemia risk in ground zero first responders

ASH 2024: High response rate, manageable adverse effects seen with epcoritamab in pretreated R/R CLL

ASH 2024: High response rate, manageable adverse effects seen with epcoritamab in pretreated R/R CLL

ASH 2024: Combining BCL-2 and BTK inhibitors shows promise in CLL

ASH 2024: Combining BCL-2 and BTK inhibitors shows promise in CLL

ASH 2024: Combination of two oral agents improves progression-free survival in previously untreated chronic lymphocytic leukaemia

ASH 2024: Combination of two oral agents improves progression-free survival in previously untreated chronic...

More from ecancer